|
Pomalidomide-C2-NH2 hydrochloride
|
|
2305369-00-8
|
|
PMX 53
|
|
219639-75-5
|
|
PhiKan083 hydrochloride
|
|
1050480-30-2
|
|
Pomalidomide 4'-alkylC3-acid
|
|
2225940-47-4
|
|
PG 01037 dihydrochloride
|
|
675599-62-9
|
|
Pomalidomide 4'-alkylC5-acid
|
|
2225940-49-6
|
|
ProINDY
|
|
719277-30-2
|
|
PRX 07034
|
|
903580-39-2
|
|
PI-3065
|
|
955977-50-1
|
|
PFM 01
|
|
1558598-41-6
|
|
PF 915275
|
|
857290-04-1
|
|
PI 828
|
|
942289-87-4
|
|
PCNA I1
|
|
444930-42-1
|
|
PKI(5-24) TFA salt
|
|
99534-03-9
|
|
PSNCBAM-1
|
|
877202-74-9
|
|
PF 3644022
|
|
1276121-88-0
|
|
Pomalidomide 4'-alkylC4-acid
|
|
2225940-48-5
|
|
PTC 209
|
|
315704-66-6
|
|
Phenyl 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranoside
|
|
3427-45-0
|
|
Pomalidomide 4'-alkylC6-acid
|
|
2225940-50-9
|
|
Pomalidomide 4'-alkylC5-amine hydrochloride
|
|
2375194-03-7
|
|
1,2,3,4,6-Penta-O-benzoyl-D-mannopyranose
|
|
96996-90-6
|
|
PF 06281355
|
|
1435467-38-1
|
|
PSEM 89S TFA
|
|
1336913-03-1
|
|
Sodium metatungstate
|
|
12141-67-2
|
|
PF 6274484
|
|
1035638-91-5
|
|
PU 02
|
|
313984-77-9
|
|
PPQ 102
|
|
931706-15-9
|
|
PYZD 4409
|
|
423148-78-1
|
|
PPY A
|
|
875634-01-8
|
|
Pyridone 6
|
|
457081-03-7
|
|
p-Methylphenylboronic acid
|
|
5720-05-8
|
|
PD 144418 oxalate
|
|
1794760-28-3
|
|
Pomalidomide 4'-alkylC3-amine hydrochloride
|
|
2154342-45-5
|
|
PKC β pseudosubstrate TFA
|
|
172308-76-8
|
|
Peptide 5 trifluoroacetate salt
|
|
916977-43-0
|
|
Pomalidomide 4'-PEG5-acid
|
|
2139348-63-1
|
|
PRIMA-1
|
|
5608-24-2
|
|
Proglumide sodium salt
|
|
99247-33-3
|
|
PF 06409577
|
|
1467057-23-3
|
|
4-Phenylnaphthalene-1-boronic Acid (contains varying amounts of Anhydride)
|
|
372521-91-0
|
|
PFI 4
|
|
900305-37-5
|
|
PF CBP1
|
|
1962928-21-7
|
|
PF 750
|
|
959151-50-9
|
|
PNU 282987
|
|
711085-63-1
|
|
PD 198306
|
|
212631-61-3
|
|
PSB 06126
|
|
1052089-16-3
|
|
PF 429242 dihydrochloride
|
|
2248666-66-0
|
|
Thalidomide-NH-C8-NH2 hydrochloride
|
|
2446474-06-0
|
|
Pimonidazole
|
|
70132-50-2
|
|
PBIT
|
|
2514-30-9
|
|
PZ-II-029
|
|
164025-44-9
|
|
PDD 00017273
|
|
1945950-21-9
|
|
Pomalidomide 4'-PEG4-amine hydrochloride
|
|
2357105-92-9
|
|
PHA 568487
|
|
527680-57-5
|
|
PKUMDL WQ 2101
|
|
304481-72-9
|
|
Pomalidomide 4'-PEG2-amine hydrochloride
|
|
2245697-87-2
|
|
PEN(mouse) TFA
|
|
1236955-25-1
|
|
1,2,3,4,6-Penta-O-benzoyl-α-D-mannopyranose
|
|
41569-33-9
|
|
PF 05190457
|
|
1334782-79-4
|
|
PACAP 6-38 TFA
|
|
143748-18-9
|
|
PD 90780
|
|
77422-99-2
|
|
PMX 205 （TFA）
|
|
514814-49-4
|
|
PF 05105679
|
|
1398583-31-7
|
|
UCM 608
|
|
151889-03-1
|
|
Paroxetine maleate
|
|
64006-44-6
|
|
Pep 2-8
|
|
1541011-97-5
|
|
1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranose
|
|
4163-65-9
|
|
9-phenyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole
|
|
1219956-30-5
|
|
Pomalidomide 4'-alkylC7-acid
|
|
2225940-51-0
|
|
PD 180970
|
|
287204-45-9
|
|
PD 166793
|
|
199850-67-4
|
|
PLpro inhibitor
|
|
1093070-14-4
|
|
Pentamidine isethionate
|
|
140-64-7
|
|
PF 06424439
|
|
1469284-79-4
|
|
PETCM
|
|
10129-56-3
|
|
2-(4-pentynoylamino)-2-deoxy-D-glucopyranose
|
|
1030262-99-7
|
|
PF 05175157
|
|
1301214-47-0
|
|
Pomalidomide 4'-PEG4-acid
|
|
2138440-81-8
|
|
PF 5274857 hydrochloride
|
|
1613439-62-5
|
|
PF-05089771 (tosylate)
|
|
1430806-04-4
|
|
PE 154
|
|
1192750-33-6
|
|
Phalloidin-TRITC
|
|
915013-10-4
|
|
PD 146176
|
|
4079-26-9
|
|
Pomalidomide-PEG2-COOH
|
|
2140807-17-4
|
|
Pomalidomide 4'-PEG1-amine hydrochloride
|
|
2154342-56-8
|
|
P1075
|
|
60559-98-0
|
|
Piclamilast
|
|
144035-83-6
|
|
PCI 29732
|
|
330786-25-9
|
|
PIT
|
|
56583-49-4
|
|
Phenyl 4-O-acetyl-2,6-di-O-benzoyl-1-thio-β-thio-β-D-galactopyranoside
|
|
152488-28-3
|
|
Propargyl α-D-Mannopyranoside
|
|
854262-01-4
|
|
PSB 1115
|
|
152529-79-8
|
|
Poly[(9,9-dioctylfluorenyl-2,7-diyl)-co-(bithiophene)
|
|
210347-56-1
|
|
PU 23
|
|
817635-93-1
|
|
PF 04885614
|
|
1480833-70-2
|
|
PA 8
|
|
878437-15-1
|
|
Pomalidomide 4'-PEG3-acid
|
|
2138440-82-9
|
|
PD 102807
|
|
23062-91-1
|
|
PA Janelia Fluor549, SE
|
|
1811539-42-0
|